Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Weber

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Biology of Reproduction|October 1, 1987
Functional differences between small and large luteal cells of the late-pregnant vs. nonpregnant cowD M Weber, P A Fields, L J Romrell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1995
Prognostic significance of magnetic resonance imaging in patients with asymptomatic multiple myelomaL A Moulopoulos, M A Dimopoulos, T L Smith, et al.
Magnetic Resonance in Medicine|November 1, 1993
Generalized matched filtering for time-resolved MR angiography of pulsatile flowY Wang, D M Weber, F R Korosec, et al.
American Journal of Clinical Pathology|October 17, 2001
Cytogenetic findings in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical courseA Mansoor, L J Medeiros, D M Weber, et al.
Blood Cancer Journal|February 13, 2016
Siltuximab (CNTO 328) with lenalidomide, bortezomib and dexamethasone in newly-diagnosed, previously untreated multiple myeloma: an open-label phase I trialJ J Shah, L Feng, S K Thomas, et al.
Leukemia|July 24, 2009
Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myelomaM A Dimopoulos, C Chen, A Spencer, et al.
Leukemia|June 14, 2013
Evidence of a role for CD44 and cell adhesion in mediating resistance to lenalidomide in multiple myeloma: therapeutic implicationsC C Bjorklund, V Baladandayuthapani, H Y Lin, et al.
Bone Marrow Transplantation|January 31, 2007
Autologous stem cell transplantation is safe and feasible in elderly patients with multiple myelomaM H Qazilbash, R M Saliba, C Hosing, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 17, 2001
Quantitative nuclear morphometry by image analysis for prediction of recurrence of ductal carcinoma in situ of the breastA Hoque, S M Lippman, I V Boiko, et al.
Oncogene|November 9, 2010
Evidence of a role for the novel zinc-finger transcription factor ZKSCAN3 in modulating Cyclin D2 expression in multiple myelomaL Yang, H Wang, S M Kornblau, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Biology of Reproduction|October 1, 1987
Functional differences between small and large luteal cells of the late-pregnant vs. nonpregnant cowD M Weber, P A Fields, L J Romrell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1995
Prognostic significance of magnetic resonance imaging in patients with asymptomatic multiple myelomaL A Moulopoulos, M A Dimopoulos, T L Smith, et al.
Magnetic Resonance in Medicine|November 1, 1993
Generalized matched filtering for time-resolved MR angiography of pulsatile flowY Wang, D M Weber, F R Korosec, et al.
American Journal of Clinical Pathology|October 17, 2001
Cytogenetic findings in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical courseA Mansoor, L J Medeiros, D M Weber, et al.
Blood Cancer Journal|February 13, 2016
Siltuximab (CNTO 328) with lenalidomide, bortezomib and dexamethasone in newly-diagnosed, previously untreated multiple myeloma: an open-label phase I trialJ J Shah, L Feng, S K Thomas, et al.
Leukemia|July 24, 2009
Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myelomaM A Dimopoulos, C Chen, A Spencer, et al.
Leukemia|June 14, 2013
Evidence of a role for CD44 and cell adhesion in mediating resistance to lenalidomide in multiple myeloma: therapeutic implicationsC C Bjorklund, V Baladandayuthapani, H Y Lin, et al.
Bone Marrow Transplantation|January 31, 2007
Autologous stem cell transplantation is safe and feasible in elderly patients with multiple myelomaM H Qazilbash, R M Saliba, C Hosing, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 17, 2001
Quantitative nuclear morphometry by image analysis for prediction of recurrence of ductal carcinoma in situ of the breastA Hoque, S M Lippman, I V Boiko, et al.
Oncogene|November 9, 2010
Evidence of a role for the novel zinc-finger transcription factor ZKSCAN3 in modulating Cyclin D2 expression in multiple myelomaL Yang, H Wang, S M Kornblau, et al.
Pageof 6